19 May 2022
Sparrow Pharmaceuticals will be presenting novel pharmacological data on its candidates for treating corticosteroid excess on 24 May at the European Congress of Endocrinology (ECE 2022).
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024
Risk of depression during menopause transition not universal
11 Apr 2024
Patients with long Covid continue to show inflammatory proteins in blood
11 Apr 2024
People with obesity and high weight linked to feeling increased pain intensity
11 Apr 2024